Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1679
    +0.0023 (+0.20%)
     

  • GBP/USD

    1.2490
    -0.0020 (-0.16%)
     

  • Bitcoin GBP

    51,071.41
    -618.75 (-1.20%)
     

  • CMC Crypto 200

    1,327.34
    -69.19 (-4.95%)
     

  • S&P 500

    5,110.33
    +61.91 (+1.23%)
     

  • DOW

    38,301.17
    +215.37 (+0.57%)
     

  • CRUDE OIL

    83.84
    +0.27 (+0.32%)
     

  • GOLD FUTURES

    2,347.70
    +5.20 (+0.22%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Silence Therapeutics plc (SLN) Q2 2021 Earnings Call Transcript

Motley Fool Transcribing, The Motley Fool
·30-min read
Silence Therapeutics plc (SLN) Q2 2021 Earnings Call Transcript

Joining me today on the call are Mark Rothera, our president and CEO, who will provide an update on the business; Dr. Giles Campion, our head of R&D and chief medical officer, who will provide an update on our clinical programs; and Craig Tooman, our chief financial officer, who will review our financials before opening the call to your questions. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in our most recent annual report on file with the SEC.

Continue reading